| Literature DB >> 24376731 |
Lifeng Liu1, Xuexin Cao1, Lin Zou1, Zongyu Li1, Xuecheng Cao1, Jinfang Cai1.
Abstract
The anterolateral thigh flap has been used for coverage of defects in the foot and ankle for years. Conventional extended anterolateral thigh flaps do not undergo thinning procedures, which limit their application. Here, a clinical series of 24 patients is reported in which extended anterolateral thigh flaps were used for posttraumatic foot and ankle reconstruction. Of the 24 flaps, 14 were simple extended anterolateral thigh fasciocutaneous flaps and 10 were thinned extended anterolateral thigh flaps. One artery and two veins, including a superficial vein and an accompanying vein, were anastomosed to vascularize each flap. Follow-up of the 24 patients ranged from 10 months to 4 years postoperatively. All 24 flaps survived successfully, except one case that had partial flap necrosis distally due to excessive thinning. The cutaneous flap territory ranged from 250 cm(2) to 400 cm(2) (mean, 297 cm(2)). Only one patient received a debulking procedure. No ulceration occurred in any of the flaps due to contact with the shoe. The extended anterolateral thigh flap is a good alternative for extensive soft tissue defects of the foot and ankle. This study also supports the high reliability and excellent vascular supply of moderate thinned extended ALT flaps.Entities:
Mesh:
Year: 2013 PMID: 24376731 PMCID: PMC3871676 DOI: 10.1371/journal.pone.0083696
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Statistical description of case series (N = 24 procedures in 24 patients).
| Pt. No | Age/sex | Defect Location | Type of flap | Flap size | Area(cm2) | No. of perforators | Complication | Followup(months) |
| 1 | 42/Male | Hind foot and heel | Extended ALT musculocutaneous perforator flap | 20×15 | 300 | 1 | None | 15 |
| 2 | 32/Male | Dorsum and sole | Extended ALT septocutaneous perforator flap | 20×16 | 320 | 1 | Flap thickness | 36 |
| 3 | 41/Female | Dorsum | Extended ALT musculocutaneous perforator flap | 18×14 | 252 | 1 | None | 21 |
| 4 | 35/Female | Ankle and dorsum | Thinned extended ALT musculocutaneous perforator flap | 25×13 | 325 | 2 | None | 14 |
| 5 | 51/Male | Ankle and dorsum | Extended ALT septocutaneous perforator flap | 22×12 | 264 | 1 | Wound infection | 32 |
| 6 | 44/Female | Ankle | Thinned extended ALT musculocutaneous perforator flap | 19×15 | 285 | 1 | None | 42 |
| 7 | 31/Male | Dorsum and sole | Extended ALT musculocutaneous perforator flap | 20×14 | 280 | 1 | None | 25 |
| 8 | 27/Male | Dorsum | Thinned extended ALT musculocutaneous perforator flap | 18×16 | 288 | 1 | None | 15 |
| 9 | 17/Female | Dorsum | Extended ALT septocutaneous perforator flap | 18×14 | 252 | 1 | None | 10 |
| 10 | 51/Male | Ankle | Extended ALT septocutaneous perforator flap | 20×14 | 280 | 1 | None | 48 |
| 11 | 47/Male | Dorsum | Thinned extended ALT musculocutaneous perforator flap | 22×15 | 330 | 1 | Partial flap necrosis | 24 |
| 12 | 36/Male | Dorsum | Extended ALT musculocutaneous perforator flap | 18×15 | 270 | 2 | None | 19 |
| 13 | 42/Male | Dorsum and sole | Thinned extended ALT musculocutaneous perforator flap | 25×16 | 400 | 3 | None | 20 |
| 14 | 29/Female | Degloving forefoot | Extended ALT musculocutaneous perforator flap | 20×15 | 300 | 1 | None | 24 |
| 15 | 46/Male | Dorsum and sole | Extended ALT septocutaneous perforator flap | 20×15 | 300 | 2 | None | 10 |
| 16 | 21/Male | Dorsum | Extended ALT musculocutaneous perforator lap | 19×13 | 247 | 1 | None | 15 |
| 17 | 51/Male | Ankle and dorsum | Thinned extended ALT musculocutaneous perforator flap | 25×14 | 350 | 2 | None | 19 |
| 18 | 26/Male | Hind foot | Thinned extended ALT musculocutaneous perforator flap | 18×15 | 270 | 1 | None | 14 |
| 19 | 32/Male | Hind foot and heel | Extended ALT musculocutaneous perforator flap | 20×15 | 300 | 2 | Skin grafting loss | 36 |
| 20 | 31/Male | Hind foot and medial ankle. | Extended ALT musculocutaneous perforator flap | 24×16 | 388 | 1 | Fatigue of climbing | 30 |
| 21 | 48/Female | Dorsum | Thinned extended ALT septocutaneous perforator flap | 19×15 | 285 | 2 | None | 10 |
| 22 | 59/Male | Degloving forefoot | Thinned extended ALT musculocutaneous perforator flap | 22×15 | 330 | 2 | Wound infection | 15 |
| 23 | 41/Male | Ankle | Extended ALT septocutaneous perforator flap | 20×13 | 260 | 1 | None | 18 |
| 24 | 33/Female | Dorsum | Thinned extended ALT musculocutaneous perforator flap | 18×14 | 250 | 2 | None | 20 |
Length by width.
Figure 1Preoperative view of extensive soft tissue defect of the dorsum and weight-bearing sole of the foot with exposure of the transverse tarsal joint.
Figure 5Appearance 14 months after debulking procedure.
Figure 6Preoperative view of extensive soft tissue defect of the dorsal foot with exposed tendon and bone.
Figure 8Early postoperative view of the flap.
Figure 9Preoperative view of extensive soft tissue defect of the degloved foot.
Figure 13Three month follow-up with healed tissue envelope.
Figure 14Preoperative view of extensive soft tissue defect over the hind foot and medial ankle.
Figure 17Two month follow-up with healed tissue envelope.